Advertisement
Research Article

Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study

  • Marta Valenciano mail,

    m.valenciano@epiconcept.fr

    Affiliation: EpiConcept, Paris, France

    X
  • Esther Kissling,

    Affiliation: EpiConcept, Paris, France

    X
  • Jean-Marie Cohen,

    Affiliation: Réseau des GROG/Open Rome, Paris, France

    X
  • Beatrix Oroszi,

    Affiliation: National Center for Epidemiology, Budapest, Hungary

    X
  • Anne-Sophie Barret,

    Affiliations: Health Protection Surveillance Centre, Dublin, Ireland, European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden

    X
  • Caterina Rizzo,

    Affiliation: National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Roma, Italy

    X
  • Baltazar Nunes,

    Affiliation: Instituto Nacional de Saúde Dr Ricardo Jorge, Lisbon, Portugal

    X
  • Daniela Pitigoi,

    Affiliations: Cantacuzino Institute, National Institute of Research – Development for Microbiology and Immunology, Bucharest, Romania, Universitatea de Medicina si Farmacie Carol Davila, Bucharest, Romania

    X
  • Amparro Larrauri Cámara,

    Affiliation: National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain

    X
  • Anne Mosnier,

    Affiliation: Réseau des GROG/Open Rome, Paris, France

    X
  • Judith K. Horvath,

    Affiliation: National Center for Epidemiology, Budapest, Hungary

    X
  • Joan O'Donnell,

    Affiliation: Health Protection Surveillance Centre, Dublin, Ireland

    X
  • Antonino Bella,

    Affiliation: National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Roma, Italy

    X
  • Raquel Guiomar,

    Affiliation: Instituto Nacional de Saúde Dr Ricardo Jorge, Lisbon, Portugal

    X
  • Emilia Lupulescu,

    Affiliation: Cantacuzino Institute, National Institute of Research – Development for Microbiology and Immunology, Bucharest, Romania

    X
  • Camelia Savulescu,

    Affiliations: EpiConcept, Paris, France, National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain

    X
  • Bruno C. Ciancio,

    Affiliation: European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

    X
  • Piotr Kramarz,

    Affiliation: European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

    X
  • Alain Moren

    Affiliation: EpiConcept, Paris, France

    X
  • Published: January 11, 2011
  • DOI: 10.1371/journal.pmed.1000388

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.